Shares of Granules India were up 4% in early morning trade on Wednesday after the company, on Tuesday, announced robust results for the quarter ended December 2018.
The company’s revenue in Q3FY19 grew 53.8% yoy to Rs631.8cr vs. Rs410.7cr in Q3FY18, while PAT grew 72.3% yoy to Rs60.3cr in Q3FY19.
Granules India Ltd is an Indian pharmaceutical manufacturing company based in Hyderabad, India. It manufactures tablets, Pharmaceutical Formulation Intermediates, and active pharmaceutical ingredients (APIs) which are distributed in over 74+ countries.
Granules India Ltd share price is currently at Rs92, up Rs3.6, or 4.07%, from its previous close of Rs88.40 on the BSE.
The company’s revenue in Q3FY19 grew 53.8% yoy to Rs631.8cr vs. Rs410.7cr in Q3FY18, while PAT grew 72.3% yoy to Rs60.3cr in Q3FY19.
Granules India Ltd is an Indian pharmaceutical manufacturing company based in Hyderabad, India. It manufactures tablets, Pharmaceutical Formulation Intermediates, and active pharmaceutical ingredients (APIs) which are distributed in over 74+ countries.
Granules India Ltd share price is currently at Rs92, up Rs3.6, or 4.07%, from its previous close of Rs88.40 on the BSE.
No comments:
Post a Comment